Jean-Pierre J Issa Selected Research

Jean-Pierre J Issa Research Topics

Disease

80	Neoplasms (Cancer) 01/2024 - 01/2002
16	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 01/2003
15	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2019 - 04/2006
10	Colonic Neoplasms (Colon Cancer) 01/2024 - 01/2002
9	Leukemia 01/2017 - 06/2002
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2023 - 04/2006
8	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2003
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 07/2002
6	Myeloid Leukemia (Leukemia, Myelocytic) 05/2017 - 05/2006
6	Carcinogenesis 11/2010 - 01/2004
4	Melanoma (Melanoma, Malignant) 12/2015 - 08/2006
4	Adenoma (Adenomas) 02/2014 - 04/2005
4	Chromosomal Instability (Chromosome Stability) 04/2009 - 11/2003
3	Carcinoma (Carcinomatosis) 01/2023 - 05/2003
3	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 07/2015 - 01/2007
3	Stomach Neoplasms (Stomach Cancer) 10/2013 - 12/2003
3	Prostatic Neoplasms (Prostate Cancer) 06/2008 - 07/2007
3	Microsatellite Instability 05/2008 - 05/2003
3	Philadelphia Chromosome 11/2007 - 07/2002
2	Neutropenia 12/2023 - 08/2006
2	Atherosclerosis 01/2023 - 01/2007
2	Inflammation (Inflammations) 11/2022 - 09/2012
2	Triple Negative Breast Neoplasms 06/2021 - 01/2018
2	Adenocarcinoma of Lung 01/2021 - 12/2009
2	Adenocarcinoma 01/2021 - 12/2009
2	Infections 02/2014 - 08/2006
2	Glioma (Gliomas) 07/2013 - 04/2011
2	Urinary Bladder Neoplasms (Bladder Cancer) 07/2011 - 07/2007
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 05/2008 - 04/2005
2	Acute Promyelocytic Leukemia 12/2007 - 10/2006
2	Myeloproliferative Disorders (Myeloproliferative Disorder) 11/2007 - 11/2005
2	Hematologic Neoplasms (Hematological Malignancy) 02/2007 - 03/2004
1	Febrile Neutropenia 12/2023
1	Pneumonia (Pneumonitis) 12/2023
1	COVID-19 01/2023
1	Pathologic Constriction (Stenosis) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Opioid-Related Disorders (Opiate Addiction) 01/2023
1	Substance-Related Disorders (Drug Abuse) 01/2023
1	Cross Infection (Nosocomial Infection) 11/2022
1	Adenocarcinoma in Situ 01/2021
1	Hyperplasia 01/2021

Drug/Important Bio-Agent (IBA)

30	DNA (Deoxyribonucleic Acid)IBA 07/2022 - 01/2002
25	Decitabine FDA Link 01/2024 - 03/2004
15	hydrogen sulfite (bisulfite)IBA 01/2021 - 05/2002
13	ChromatinIBA 01/2024 - 08/2003
12	Histones (Histone)IBA 07/2022 - 01/2002
11	MethyltransferasesIBA 01/2019 - 05/2003
8	guadecitabineIBA 12/2023 - 09/2015
8	Azacitidine (5 Azacytidine)FDA Link 12/2023 - 05/2006
7	Calcibiotic Root Canal SealerIBA 02/2014 - 01/2004
6	Biomarkers (Surrogate Marker)IBA 11/2022 - 04/2008
6	Protein Isoforms (Isoforms)IBA 08/2017 - 01/2004
6	Histone Deacetylase InhibitorsIBA 01/2017 - 08/2003
6	Estrogen ReceptorsIBA 01/2017 - 05/2002
6	Imatinib Mesylate (Gleevec)FDA Link 01/2011 - 07/2002
5	Proteins (Proteins, Gene)FDA Link 04/2011 - 10/2006
5	CytosineIBA 05/2008 - 01/2002
3	EnzymesIBA 01/2023 - 01/2010
3	Hormones (Hormone)IBA 01/2018 - 01/2007
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2017 - 12/2007
3	retinoic acid receptor betaIBA 06/2009 - 05/2003
3	Lysine (L-Lysine)FDA Link 06/2008 - 08/2003
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2007 - 04/2004
3	A-Form DNA (A-DNA)IBA 06/2005 - 12/2003
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2023 - 07/2007
2	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2018
2	Transcription Factors (Transcription Factor)IBA 07/2015 - 10/2005
2	PlatinumIBA 01/2015 - 01/2015
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 10/2013 - 06/2009
2	Retroelements (Retrotransposon)IBA 10/2012 - 10/2010
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2012 - 06/2011
2	Cadherins (E-Cadherin)IBA 01/2010 - 06/2004
2	GuanineIBA 05/2008 - 02/2003
2	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 12/2007 - 10/2006
2	Messenger RNA (mRNA)IBA 11/2007 - 05/2006
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2007 - 08/2006
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 05/2003 - 04/2002
2	T-Type Calcium Channels (T-Type Calcium Channel)IBA 05/2003 - 05/2002
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2003 - 05/2002
2	bcr-abl Fusion ProteinsIBA 07/2002 - 07/2002
1	Cyclin-Dependent Kinase 9IBA 01/2024
1	atezolizumabIBA 01/2023
1	Opioid Analgesics (Opioids)IBA 01/2023
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2023
1	CreatinineIBA 01/2023
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2023
1	HomocysteineIBA 01/2023
1	LigandsIBA 01/2023
1	Methadone (Dolophine)FDA LinkGeneric 01/2023
1	Naloxone (Narcan)FDA LinkGeneric 01/2023
1	Lipoprotein(a)IBA 01/2023
1	16S Ribosomal RNAIBA 11/2022
1	Adenosine (Adenocard)FDA LinkGeneric 07/2022
1	ToyocamycinIBA 07/2022
1	Cell-Free Nucleic AcidsIBA 01/2021

Therapy/Procedure

29	Therapeutics 01/2023 - 12/2003
6	Drug Therapy (Chemotherapy) 07/2022 - 10/2007
2	Aftercare (After-Treatment) 01/2023 - 12/2003
1	Induction Chemotherapy 12/2023